The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality
Open accessAbstract
OBJECTIVE: To assess the impact of the NHS breast screening programme on mortality from breast cancer in women aged 55-69 years over the period 1990-8. DESIGN: Age cohort model with data for 1971-89 used to predict mortality for 1990-8 with assumption of no major effect from screening or improvements in treatment until after 1989. Effect of screening and other factors on mortality estimated by comparing three year moving averages of observed mortality with those predicted (by five year age groups from 50-54 to 75-79), the effect of screening being restricted to certain age groups. SETTING: England and Wales. SUBJECTS: Women aged 40 to 79 years. RESULTS: Compared with predicted mortality in the absence of screening or other effects the total reduction in mortality from breast cancer in 1998 in women aged 55-69 was estimated as 21.3%. Direct effect of screening was estimated as 6.4% (range of estimates from 5.4-11.8%). Effect of all other factors (improved treatment with tamoxifen and chemotherapy, and earlier presentation outside the screening programme) was estimated as 14.9% (range 12.2-14.9%). CONCLUSIONS: By 1998 both screening and other factors, including improvements in treatment, had resulted in substantial reductions in mortality from breast cancer. Many deaths in the 1990s will be of women diagnosed in the 1980s and early 1990s, before invitation to screening. Further major effects from screening and treatment are expected, which together with cohort effects should result in further substantial reductions in mortality from breast cancer, particularly for women aged 55-69, over the next 10 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY
Tabár, L., Gad, A., Holmberg, L. H., Ljungquist, U., Fagerberg, C. J. G., Baldetorp, L., Gröntoft, O., Lundström, B., Månson, J. C., Eklund, G., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92204-4 · Cited by 1,781
Early Breast Cancer Trialists’ Collaborative Group, & Peto, R. (1993) · Recent Results in Cancer Research · doi:10.1007/978-3-642-84745-5_21 · Cited by 958
Trends in Cancer Incidence, Survival and Mortality
Estève, J., & Coleman, M. (2009) · Husband and Reznek's Imaging in Oncology, Third Edition · doi:10.3109/9780415874984-2 · Cited by 761
Models for temporal variation in cancer rates. I: Age–period and age–cohort models
Clayton, D., & Schifflers, E. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060405 · Cited by 685
A policy framework for commissioning cancer services
Whitehouse, M. (1995) · BMJ · doi:10.1136/bmj.310.6992.1425 · Cited by 506
Trends in cancer incidence and mortality
(1994) · Cancer Causes & Control · doi:10.1007/bf01830253 · Cited by 462
Long-term survival of patients with breast cancer: a study of the curability of the disease.
Langlands, A. O., Pocock, S., Kerr, G. R., & Gore, S. M. (1979) · BMJ · doi:10.1136/bmj.2.6200.1247 · Cited by 229
Quinn, M., & Allen, E. (1995) · BMJ · doi:10.1136/bmj.311.7017.1391 · Cited by 176
Holmberg, L., Ljungquist, U., Baldetorp, L., EKLUND, G. A., & Pettersson, F. (1985) · Cited by 116
Stockton, D., Davies, T. W., Day, N., & McCann, J. (1997) · BMJ · doi:10.1136/bmj.314.7079.472 · Cited by 100
Five Years of Tamoxifen--or More?
Peto, R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.24.1791 · Cited by 69
Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy
&NA; (1992) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199206000-00018 · Cited by 54
The NHS breast screening programme
McMahon, M. J., Sharma, N., & Dodwell, D. (2013) · British Journal of Hospital Medicine · doi:10.12968/hmed.2013.74.8.458 · Cited by 16
Cited by
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Global cancer statistics in the year 2000
Parkin, D. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00486-7 · Cited by 2,445
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Screening, T. I. U. P. O. B. C., Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.177 · Cited by 1,069
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
Forouzanfar, M. H., Foreman, K. J., Delossantos, A. M., Lozano, R., Lopez, A. D., Murray, C. J. L., & Naghavi, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61351-2 · Cited by 1,009
Metadata
- Authors
- Blanks, R. G.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-09-16
- Volume
- 321
- Issue
- 7262
- Pages
- 665-669
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W2078574517
- Cited by
- 380
- References
- 14
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.